BioArctic AB (CHIX:BIOABS) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BIOABS BioArctic AB CHIX:BIOABS
74 GF Score
Price kr324.30
GF Value kr467.17
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is BioArctic AB Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:BIOABS
74GF Score
BioArctic AB CHIX:BIOABS
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioArctic AB (CHIX:BIOABS) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of kr324.30 is trading 30.6% below its estimated GF Value™ of kr467.17. GuruFocus considers BioArctic AB to be Possible Value Trap.

Key valuation signals for CHIX:BIOABS:

  • Interest Received:
  • GF Value™: kr467.17 vs. price of kr324.30 (30.6% below fair value)
  • GF Score™: 74/100 with 8 warning signs

No single metric tells the full story. See the CHIX:BIOABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
74GF Score

Get the complete analysis for CHIX:BIOABS

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr324.30
Price
kr467.17
GF Value